Terms: = Gastric cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Treatment
74 results:
1. Promising Response of Olaparib in Patient With Germline
Chan KH; Rutazanaa D; Wray C; Thosani N; Yang V; Cen P
J Investig Med High Impact Case Rep; 2024; 12():23247096241240176. PubMed ID: 38504422
[TBL] [Abstract] [Full Text] [Related]
2. Polo‑like kinase 1 selective inhibitor BI2536 (dihydropteridinone) disrupts centrosome homeostasis via atm‑ERK cascade in adrenocortical carcinoma.
Lin RC; Chao YY; Lien WC; Chang HC; Tsai SW; Wang CY
Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37477142
[TBL] [Abstract] [Full Text] [Related]
3. Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.
Özdemir Z; Çevik E; Öksüzoğlu ÖBÇ; Doğan M; Ateş Ö; Esin E; Bilgetekin İ; Demirci U; Köseoğlu Ç; Topal A; Karadurmuş N; Erdem HB; Bahsi T
Mutat Res; 2023; 827():111831. PubMed ID: 37453313
[TBL] [Abstract] [Full Text] [Related]
4. N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer.
Yang J; Xu P; Chen Z; Zhang X; Xia Y; Fang L; Xie L; Li B; Xu Z
Cancer Lett; 2023 Apr; 558():216092. PubMed ID: 36806557
[TBL] [Abstract] [Full Text] [Related]
5. [gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
[No Abstract] [Full Text] [Related]
6. Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer.
Cheng Y; Bu D; Zhang Q; Sun R; Lyle S; Zhao G; Dong L; Li H; Zhao Y; Yu J; Hao X
J Adv Res; 2023 Sep; 51():121-134. PubMed ID: 36351537
[TBL] [Abstract] [Full Text] [Related]
7. Network analysis reveals that the tumor suppressor lncRNA GAS5 acts as a double-edged sword in response to DNA damage in gastric cancer.
Gupta S; Panda PK; Luo W; Hashimoto RF; Ahuja R
Sci Rep; 2022 Oct; 12(1):18312. PubMed ID: 36316351
[TBL] [Abstract] [Full Text] [Related]
8. Machine learning-based gray-level co-occurrence matrix signature for predicting lymph node metastasis in undifferentiated-type early gastric cancer.
Wei X; Yan XJ; Guo YY; Zhang J; Wang GR; Fayyaz A; Yu J
World J Gastroenterol; 2022 Sep; 28(36):5338-5350. PubMed ID: 36185632
[TBL] [Abstract] [Full Text] [Related]
9. Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer.
Kwon M; Kim G; Kim R; Kim KT; Kim ST; Smith S; Mortimer PGS; Hong JY; Loembé AB; Irurzun-Arana I; Koulai L; Kim KM; Kang WK; Dean E; Park WY; Lee J
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35790315
[TBL] [Abstract] [Full Text] [Related]
10. Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review.
Alugoju P; Krishna Swamy VKD; Anthikapalli NVA; Tencomnao T
Crit Rev Food Sci Nutr; 2023; 63(31):10709-10774. PubMed ID: 35708049
[TBL] [Abstract] [Full Text] [Related]
11. atm Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
El Jabbour T; Misyura M; Cowzer D; Zimmermann M; Rimkunas V; Marra A; Derakhshan F; Selenica P; Parilla M; Setton JS; Ceyhan-Birsoy O; Kemel Y; Catchings A; Ranganathan M; Ku GY; Janjigian YY; Zinda M; Koehler M; Stadler Z; Shia J; Reis-Filho JS; Mandelker D
J Natl Cancer Inst; 2022 May; 114(5):761-770. PubMed ID: 35078243
[TBL] [Abstract] [Full Text] [Related]
12. The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
Venizelos A; Elvebakken H; Perren A; Nikolaienko O; Deng W; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Krogh M; Sorbye H; Knappskog S
Endocr Relat Cancer; 2021 Nov; 29(1):1-14. PubMed ID: 34647903
[TBL] [Abstract] [Full Text] [Related]
13. The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancer.
van Velzen MJM; Pape M; Dijksterhuis WPM; Slingerland M; van Voorthuizen T; Beerepoot LV; Creemers GJ; Derks S; Mohammad NH; Verhoeven RHA; van Laarhoven HWM
Eur J Cancer; 2021 Oct; 156():60-69. PubMed ID: 34425405
[TBL] [Abstract] [Full Text] [Related]
14. IL-15-induced lymphocytes as adjuvant cellular immunotherapy for gastric cancer.
Hu Y; Liu D; Cui P; Zhang W; Chen H; Piao C; Lu Y; Liu X; Wang Y; Liu J; Lu X
Invest New Drugs; 2021 Dec; 39(6):1538-1548. PubMed ID: 34387808
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
[TBL] [Abstract] [Full Text] [Related]
16. Long-term oncological outcomes of laparoscopic gastrectomy for grossly early gastric cancer-mimicking advanced gastric cancer: Propensity score matching analysis.
Oh SE; An JY; Choi MG; Sohn TS; Bae JM; Lee JH
Medicine (Baltimore); 2020 Dec; 99(49):e23441. PubMed ID: 33285738
[TBL] [Abstract] [Full Text] [Related]
17. Hydrogen peroxide and Helicobacter pylori extract treatment combined with APE1 knockdown induce DNA damage, G2/M arrest and cell death in gastric cancer cell line.
Manoel-Caetano FS; Rossi AFT; Ribeiro ML; Prates J; Oliani SM; Silva AE
DNA Repair (Amst); 2020 Dec; 96():102976. PubMed ID: 33065487
[TBL] [Abstract] [Full Text] [Related]
18. Screening and identification of key biomarkers in alimentary tract cancers: A bioinformatic analysis.
Cai Z; Wei Y; Chen S; Gong Y; Fu Y; Dai X; Zhou Y; Yang H; Tang L; Liu H
Cancer Biomark; 2020; 29(2):221-233. PubMed ID: 32623389
[TBL] [Abstract] [Full Text] [Related]
19. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW
Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910
[TBL] [Abstract] [Full Text] [Related]
20. Pharmacology of the atm Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically.
Riches LC; Trinidad AG; Hughes G; Jones GN; Hughes AM; Thomason AG; Gavine P; Cui A; Ling S; Stott J; Clark R; Peel S; Gill P; Goodwin LM; Smith A; Pike KG; Barlaam B; Pass M; O'Connor MJ; Smith G; Cadogan EB
Mol Cancer Ther; 2020 Jan; 19(1):13-25. PubMed ID: 31534013
[TBL] [Abstract] [Full Text] [Related]
[Next]
